Delcath Systems, Inc.

  • Market Cap: Micro Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: US24661P8077
USD
9.07
-0.67 (-6.88%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationScore
Click here to find our call on this stock
Strong Sell
Sell
Hold
Buy
Strong Buy

Comparison

Company
Score
Quality
Valuation
Financial
Technical
Delcath Systems, Inc.
Akili, Inc.
Eargo, Inc.
iCAD, Inc.
ReWalk Robotics Ltd.
IRIDEX Corp.
Sensus Healthcare, Inc.
Vivani Medical, Inc.
DermTech, Inc.
Meihua International Medical Technologies Co., Ltd.
Daxor Corp.

Why is Delcath Systems, Inc. ?

1
With a growth in Net Sales of 0.8%, the company declared Very Positive results in Sep 25
  • The company has declared positive results for the last 5 consecutive quarters
  • OPERATING CASH FLOW(Y) Highest at USD 13.25 MM
  • NET PROFIT(HY) Higher at USD 3.53 MM
  • ROCE(HY) Highest at 1.94%
2
With ROE of 6.86%, it has a fair valuation with a 2.97 Price to Book Value
  • Over the past year, while the stock has generated a return of -32.51%, its profits have risen by 129.2% ; the PEG ratio of the company is 0.4
3
High Institutional Holdings at 69.22%
  • These investors have better capability and resources to analyse fundamentals of companies than most retail investors.
  • Their stake has increased by 2.57% over the previous quarter.
4
Underperformed the market in the last 1 year
  • Even though the market (S&P 500) has generated returns of 14.90% in the last 1 year, the stock has hugely underperformed and has generate negative returns of -32.51% returns
stock-recommendationReal-Time Research Report

Verdict Report

How much should you hold?

  1. Overall Portfolio exposure to Delcath Systems, Inc. should be less than 10%
  2. Overall Portfolio exposure to Pharmaceuticals & Biotechnology should be less than 30%

(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)

When to exit? - We will constantly monitor the company and suggest at the appropriate time to exit from the stock

Is Delcath Systems, Inc. for you?

High Risk, High Return

Absolute
Risk Adjusted
Volatility
Delcath Systems, Inc.
-32.51%
0.59
59.13%
S&P 500
14.9%
0.77
19.29%
stock-recommendationQuality
stock-summaryManagement Risk
stock-summaryGrowth
stock-summaryCapital Structure
stock-recommendation
Quality grade scale :

Below Average, Average, Good, Excellent

Quality key factors

Factor
Value
Sales Growth (5y)
116.85%
EBIT Growth (5y)
18.25%
EBIT to Interest (avg)
-18.17
Debt to EBITDA (avg)
Negative Net Debt
Net Debt to Equity (avg)
-0.73
Sales to Capital Employed (avg)
0.67
Tax Ratio
1.39%
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
69.22%
ROCE (avg)
0
ROE (avg)
0
stock-recommendationValuation

Valuation Scorecard stock-summary

stock-recommendation
Valuation grade scale :

Very Risky, Risky, Very Expensive, Expensive, Fair, Attractive, Very Attractive

Valuation Key Factors stock-summary

Factor
Value
P/E Ratio
43
Industry P/E
Price to Book Value
2.97
EV to EBIT
42.85
EV to EBITDA
40.71
EV to Capital Employed
9.68
EV to Sales
3.17
PEG Ratio
0.37
Dividend Yield
NA
ROCE (Latest)
22.59%
ROE (Latest)
6.86%
stock-recommendationTechnicals

Technical key factors

Indicator
Weekly
Monthly
MACD
Bearish
Mildly Bullish
RSI
No Signal
No Signal
Bollinger Bands
Sideways
Mildly Bearish
Moving Averages
Bearish (Daily)
KST
Bearish
Mildly Bearish
Dow Theory
Mildly Bullish
No Trend
OBV
Mildly Bullish
Mildly Bullish
stock-recommendation Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish  Turned 
Technical Movement
stock-recommendationFinancial Trend

Financial Trend Scorecard stock-summary

stock-recommendation
Financial Trend scale:

Very Negative, Negative, Flat, Positive, Very Positive, Outstanding

27What is working for the Company
OPERATING CASH FLOW(Y)

Highest at USD 13.25 MM

NET PROFIT(HY)

Higher at USD 3.53 MM

ROCE(HY)

Highest at 1.94%

RAW MATERIAL COST(Y)

Fallen by -2.23% (YoY

CASH AND EQV(HY)

Highest at USD 169.92 MM

DEBTORS TURNOVER RATIO(HY)

Highest at 7.44 times

NET SALES(Q)

At USD 20.56 MM has Grown at 17.1%

-8What is not working for the Company
PRE-TAX PROFIT(Q)

At USD 0.38 MM has Fallen at -77.41%

NET PROFIT(Q)

At USD 0.83 MM has Fallen at -44.07%

Here's what is working for Delcath Systems, Inc.

Operating Cash Flow
Highest at USD 13.25 MM and Grown
In each year in the last three years
MOJO Watch
The company has generated higher cash revenues from business operations

Operating Cash Flows (USD MM)

Net Sales
At USD 20.56 MM has Grown at 17.1%
over average net sales of the previous four periods of USD 17.56 MM
MOJO Watch
Near term sales trend is positive

Net Sales (USD MM)

Cash and Eqv
Highest at USD 169.92 MM
in the last six Semi-Annual periods
MOJO Watch
Short Term liquidity is improving

Cash and Cash Equivalents

Debtors Turnover Ratio
Highest at 7.44 times
in the last five Semi-Annual periods
MOJO Watch
Company has been able to sell its Debtors faster

Debtors Turnover Ratio

Raw Material Cost
Fallen by -2.23% (YoY)
MOJO Watch
The company's ability to pass on the cost of raw materials to customers has improved; this may lead to a rise in profit margin

Raw Material Cost as a percentage of Sales

Here's what is not working for Delcath Systems, Inc.

Pre-Tax Profit
At USD 0.38 MM has Fallen at -77.41%
over average net sales of the previous four periods of USD 1.66 MM
MOJO Watch
Near term Pre-Tax Profit trend is very negative

Pre-Tax Profit (USD MM)

Net Profit
At USD 0.83 MM has Fallen at -44.07%
over average net sales of the previous four periods of USD 1.48 MM
MOJO Watch
Near term Net Profit trend is very negative

Net Profit (USD MM)